Chronic Spontaneous Urticaria: Bringing It Back Where It Belongs – A Disease State Update
At the 2026 ODAC Dermatology Conference, we had the privilege of learning about chronic spontaneous urticaria (CSU) from Dr. Adam Friedman, MD, FAAD, Professor and Chair of Dermatology at The George Washington University School of Medicine. CSU can be a maddening, exhausting condition for patients, with a relapsing disease course and without identifiable triggers. Given that symptoms are often abs …
At the 2026 ODAC Dermatology Conference, we had the privilege of learning about chronic spontaneous urticaria (CSU) from Dr. Adam Friedman, MD, FAAD, Professor and Chair of Dermatology at The George Washington University School of Medicine. CSU can be a maddening, exhausting condition for patients, with a relapsing disease course and without identifiable triggers. Given that symptoms are often abs … 
Originally published May 26, 2021; updated February 23, 2026 by the Next Steps in Derm Editorial Team with refreshed links and expanded guidance on treating nail disorders.
Just as pigmented lesions on the skin can vary widely from freckles to lentigines to nevi to melanoma, similar pigmented lesions can be seen in nails. Melanonychia, brown … 
Electronic cigarette use (also known as vaping) is on the rise, according to the Centers for Disease Control (CDC). Data from the CDC’s National Health Interview Survey shows vaping increased from 4.5% in 2019 to 6.5% in 2023. While vaping is generally considered less harmful than traditional cigarette smoking, vaping is associated with acute lung injury and inflammation. Vapes contain cancer-ca … 
A photodynamic therapy revolution (PDT) is upon us, according to San Diego dermatologist Neal Bhatia, MD, FAAD. In an interview with Next Steps in Derm, in partnership with the ODAC Dermatology Conference, Dr. Bhatia outlines new PDT devices that are on the market and their benefits for both the clinician and patient. Watch as Dr. Bhatia shares his advice for an efficient and effective PDT schedul … 
The 2026 ODAC Conference featured an expert panel discussion on evolving strategies for the use of hedgehog pathway inhibitors (HHIs), with a focus on practical clinical decision-making for dermatologists. Dr. Vishal Patel and Dr. C. William Hanke reviewed how HHIs have expanded treatment options for patients with locally advanced and metastatic basal cell carcinoma (BCC).
Background and Rational …